346 related articles for article (PubMed ID: 33039403)
1. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
2. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
3. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
5. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
6. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
[TBL] [Abstract][Full Text] [Related]
7. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
Cho YS; Kim Y; Sohn JH
Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
[TBL] [Abstract][Full Text] [Related]
8. Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Cheng X; Tang Y; He Q; Song J; Wang K; Li H; Huang J; Wang W; Li J; Wang H; Tu M; Chen J; Yuan G; Kang S; Liu H; Zhang X; Luo W; Ji Y; Lan X; Zhou L; Lai Q; Luo X; Wu Q; Zhou D; Tan Y; Chen J; Zhang X
Aliment Pharmacol Ther; 2024 Mar; 59(5):680-691. PubMed ID: 38155565
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
[TBL] [Abstract][Full Text] [Related]
11. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonic spleen thickness-based indexes surpass Baveno VI criteria in high-risk gastroesophageal varices detection.
Liang XE; Hu XM; Wang HY; Dai L; Lin XY; Chen JJ; Chen YP; Wen B; Jiang RL
Hepatol Int; 2022 Jun; 16(3):649-657. PubMed ID: 35412215
[TBL] [Abstract][Full Text] [Related]
13. A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.
Stefanescu H; Marasco G; Calès P; Fraquelli M; Rosselli M; Ganne-Carriè N; de Ledinghen V; Ravaioli F; Colecchia A; Rusu C; Andreone P; Mazzella G; Festi D
Liver Int; 2020 Jan; 40(1):175-185. PubMed ID: 31444849
[TBL] [Abstract][Full Text] [Related]
14. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
15. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
16. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Wu S; Shi Y; Chen S; Kong Y; Ma H; Ou X; Jia J; You H
Liver Int; 2021 Feb; 41(2):369-377. PubMed ID: 33277803
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
19. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.
Puigvehí M; Londoño MC; Torras X; Lorente S; Vergara M; Morillas RM; Masnou H; Serrano T; Miquel M; Gallego A; Lens S; Carrión JA
J Gastroenterol; 2020 Feb; 55(2):205-216. PubMed ID: 31493238
[TBL] [Abstract][Full Text] [Related]
20. Validation of Spleen Shear Wave Elastography for the Screening of High-risk Varices in Patients with Compensated Advanced Chronic Liver Disease.
Joseph RC; Devadas K; Varghese J; Oommen TT; Hareendran A; Nahaz N; Narayanan V; George B
J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
